Detalhe da pesquisa
1.
Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
Cytokine
; 176: 156534, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354516
2.
T follicular helper cells and T peripheral helper cells in rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 82(11): 1371-1381, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414520
3.
Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis.
Rheumatology (Oxford)
; 62(3): 1296-1305, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35799366
4.
Significant association of CX3CR1+CD8 T cells with aging and distinct clinical features in Sjögren's syndrome and IgG4-related disease.
Clin Exp Rheumatol
; 41(12): 2409-2417, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812481
5.
Distinct impact of malignancy and allergy on the clinical and immunological features of IgG4-related disease.
Clin Exp Rheumatol
; 41(9): 1754-1761, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719757
6.
Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy.
Rheumatol Int
; 43(3): 545-549, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152056
7.
Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.
Mod Rheumatol
; 33(5): 982-989, 2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112482
8.
Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
Rheumatology (Oxford)
; 61(2): 490-501, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34363463
9.
Dropped head in systemic sclerosis: a case based review.
Rheumatol Int
; 42(8): 1483-1489, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223951
10.
Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker.
Rheumatology (Oxford)
; 60(2): 967-975, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33167029
11.
[ALLERGIC DISEASES IN ADULT-ONSET STILL'S DISEASE AND RHEUMATOID ARTHRITIS].
Arerugi
; 70(8): 965-975, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34588356
12.
Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review.
Ann Hematol
; 99(11): 2463-2475, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32964342
13.
Cytokines, growth factors and proteases in medium and large vessel vasculitis.
Clin Immunol
; 206: 33-41, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772599
14.
Follicular helper T cells in the pathogenesis of IgG4-related disease.
Rheumatology (Oxford)
; 57(2): 236-245, 2018 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28460058
15.
Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease.
Cytokine
; 110: 416-419, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29861381
16.
Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Clin Exp Rheumatol
; 36 Suppl 112(3): 157-164, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29465360
17.
Risk factors of relapse following glucocorticoid tapering in IgG4-related disease.
Clin Exp Rheumatol
; 36 Suppl 112(3): 186-189, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846165
18.
T follicular helper cells mediate local production of allergen-specific IgE and IgG4.
J Allergy Clin Immunol
; 150(5): 1045-1047, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588899
19.
Tocilizumab for the treatment of polyarteritis nodosa: a systematic literature review. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar et al.
Ann Rheum Dis
; 81(10): e204, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907804
20.
Interleukin-4 as an emerging therapeutic target for IgG4-related disease.
Ann Rheum Dis
; 81(2): e28, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959595